We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
(+18%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$101M |
| 2 |
Alcon
ALC
|
+$87.1M |
| 3 |
Otis Worldwide
OTIS
|
+$68.8M |
| 4 |
MRSH
Marsh
MRSH
|
+$50M |
| 5 |
Merck
MRK
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$56M |
| 2 |
JPMorgan Chase
JPM
|
+$42.7M |
| 3 |
Amazon
AMZN
|
+$38.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$36.5M |
| 5 |
Microsoft
MSFT
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.31% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Dolby
DLB
$5.79B
| $2.27M | 0.01% |
34,542
-33,088
| -49% | -$1.98M |
|
|
AVLR
727
DELISTED
Avalara, Inc.
AVLR
| $2.27M | 0.01% |
+17,095
| New | +$1.68M |
|
|
MRTX
728
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.27M | 0.01% |
19,911
-26,816
| -57% | -$2.6M |
|
|
Y
729
DELISTED
Alleghany Corp
Y
| $2.27M | 0.01% |
4,647
+1,389
| +43% | +$719K |
|
|
LOGM
730
DELISTED
LogMein, Inc.
LOGM
| $2.27M | 0.01% |
26,777
-16,819
| -39% | -$1.43M |
|
731
Viking Therapeutics
VKTX
$4B
| $2.27M | 0.01% |
314,580
-280,121
| -47% | -$1.86M |
|
732
Ionis Pharmaceuticals
IONS
$9.4B
| $2.27M | 0.01% |
38,449
-37,284
| -49% | -$2.07M |
|
|
CTRA
733
DELISTED
Coterra Energy
CTRA
| $2.27M | 0.01% |
131,845
-8,910
| -6% | -$173K |
|
|
XLRN
734
DELISTED
Acceleron Pharma
XLRN
| $2.26M | 0.01% |
23,753
-18,680
| -44% | -$1.8M |
|
735
Watts Water Technologies
WTS
$13.1B
| $2.26M | 0.01% |
27,928
-17,126
| -38% | -$1.38M |
|
|
VER
736
DELISTED
VEREIT, Inc.
VER
| $2.26M | 0.01% |
70,363
+20,549
| +41% | +$572K |
|
737
Maximus
MMS
$3.1B
| $2.26M | 0.01% |
32,100
-32,406
| -50% | -$2.18M |
|
|
ACIA
738
DELISTED
Acacia Communications Inc
ACIA
| $2.26M | 0.01% |
33,611
-20,302
| -38% | -$1.38M |
|
|
ALLK
739
DELISTED
Allakos
ALLK
| $2.25M | 0.01% |
+31,381
| New | +$2.1M |
|
740
Protolabs
PRLB
$2.13B
| $2.24M | 0.01% |
19,950
-28,616
| -59% | -$2.94M |
|
741
Boston Beer
SAM
$1.92B
| $2.24M | 0.01% |
4,171
-6,188
| -60% | -$3M |
|
|
IPG
742
DELISTED
Interpublic Group of Companies
IPG
| $2.22M | 0.01% |
129,508
-6,186
| -5% | -$102K |
|
743
DaVita
DVA
$11.7B
| $2.22M | 0.01% |
28,061
-3,807
| -12% | -$297K |
|
744
Neurocrine Biosciences
NBIX
$16.6B
| $2.22M | 0.01% |
18,199
-22,144
| -55% | -$2.45M |
|
745
SEI Investments
SEIC
$12.6B
| $2.2M | 0.01% |
40,000
-4,603
| -10% | -$241K |
|
746
Lear
LEA
$8.18B
| $2.19M | 0.01% |
20,072
-1,370
| -6% | -$136K |
|
747
Immunovant
IMVT
$8.25B
| $2.19M | 0.01% |
+89,738
| New | +$1.92M |
|
|
YMAB
748
DELISTED
Y-mAbs Therapeutics
YMAB
| $2.17M | 0.01% |
50,206
-82,407
| -62% | -$3.12M |
|
|
GBT
749
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.17M | 0.01% |
34,345
-36,686
| -52% | -$2.52M |
|
750
GDS Holdings
GDS
$6.41B
| $2.16M | 0.01% |
27,100
+5,230
| +24% | +$324K |
|
Similar funds
QCM
NAMI
Aviva's Q2 2020 Portfolio in Review
As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
- Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
- Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
- Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
- Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
- Aviva opened 49 new positions and closed 36 in Q2 2020.
- Aviva's portfolio value rose 18% quarter-over-quarter to $16B.
Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.